classic.clinicaltrials.gov
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days RSS 源
直接获取 ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days 的最新更新，更新一发布就能看到。
最新文章
在常用阅读平台获取 ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days
关注 ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days 的人也关注了
-
Incyte Corporation SEC Filings investor.incyte.com
-
Astex astx.com
-
SUMITOMO PHARMA Co., Ltd. : News Releases sumitomo-pharma.com
-
Investor Relations | Karyopharm Therapeutics investors.karyopharm.com
-
-
Pegasys (peginterferon alfa-2a) - pharmaand GmbH ec.europa.eu
-
-
Press releases gsk.com
探索更多 RSS 订阅源
-
ClinicalTrials.gov: CLDN18.2 | Last update posted in the last 2 days classic.clinicaltrials.gov
-
-
问题
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days 的 RSS 订阅源网址是什么？
订阅源地址为 https://classic.clinicaltrials.gov/ct2/results/rss.xml?rcv_d=14&lup_d=2&&sel_rss=new14&cond=%22myelofibrosis+%5C%28MF%5C%29%22+OR+%22Polycythemia+Vera+%5C%28PV%5C%29%22+OR+%22Essential+Thrombocythemia+%5C%28ET%5C%29%22+OR+%22Myeloproliferative+Neoplasm+%5C%28MPN%5C%29%22&count=10000。将其粘贴到任意 RSS 阅读器中，或点击“立即关注”在 Feeder 中阅读。
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days 多久发布一次？
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days 的发布频率为 每周约 5 次。 最近一篇文章发布于 4 days前。
ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days 的 RSS 订阅源是否正常？
是的。Feeder 于 1 minute前检查过，订阅源响应正常。
如何在 Feeder 中关注 ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days？
点击“立即关注”；如果还没有账户，请先注册。 Feeder 免费套餐最多支持 200 个订阅源，可在网页、iPhone 和 Android 上使用。无需信用卡。
在 Feeder 中关注 ClinicalTrials.gov: "myelofibrosis \(MF\)" OR "Polycythemia Vera \(PV\)" OR "Essential Thrombocythemia \(ET\)" OR "Myeloproliferative Neoplasm \(MPN\)" | First posted in the last 14 days | Last update posted in the last 2 days
Feeder 免费套餐最多支持 200 个订阅源，可在网页、iPhone 和 Android 上使用。无需信用卡。